Vice President, Global Head Multiple Sclerosis and Neuroimmunology

Key Responsibilities

• Spearhead the assigned Disease Area in partnership with the GPS Disease Area Head (DAH).
• Establish and lead a fit-for-purpose DA Team with DA leaders from across the Roche Group.
• Represent late-stage development and contribute to the overall portfolio strategy with internal and external stakeholders.
• Lead and/or define, in collaboration with functions across the drug development value chain, and in alignment with the DA strategy, asset strategies, clinical development plans, target product profiles, and clinical development stage transition decision criteria to ensure alignment with the DA strategy and achievement of the internal criteria (i.e. the Bar) for scientific rigor, patient benefit, and value.
• Be an active member of the therapeutic area leadership team, contributing to the definition and execution of the therapeutic area strategy with an enterprise mindset.
• Accountable for strategic oversight, management, and prioritization of molecule enabling activities.

Qualifications

• MD or MD/PhD with board certification/eligibility in a neurology specialty is strongly preferred.
• 10+ years of clinical development experience.
• Proven leadership in the relevant disease area, which may be demonstrated by 5+ years in a clinical development leadership position within the biopharmaceutical industry or strong academic track record including clinical/scientific research and publication.
• Proven experience with global regulatory submissions (IND, BLA, NDA) and active participation in meetings with Health Authorities strongly preferred.
• Proven experience in managing, leading and developing people, including mentoring, coaching, and fostering career growth. Direct management (at least 5 years) of multiple direct reports is preferred.